Home / Media Centre / Company News / PJSC SIC “BCPP” STARTED PRODUCTION OF THE NEW PRODUCT MONTEL
02.09.2012
PJSC SIC “BCPP” STARTED PRODUCTION OF THE NEW PRODUCT MONTEL
Therapeutic indications.
An anti-asthma agent. A selective and orally active leukotriene receptor blocker.
-
12.10.2012
PARTICIPATION IN CPHI WORLDWIDE 2012, MADRID
-
12.10.2012
PJSC SIC “BCPP” STARTED PRODUCTION OF THE NEW PRODUCT MIRAXOL
-
26.07.2012
PJSC SIC “BCPP” STARTED PRODUCTION OF THE NEW PRODUCT TAMSULID